✦ LIBER ✦

5199 POSTER Phase II Study of Combined Modality Treatment in Patients With Triple Negative Breast Cancer (TN-BC)

✍ Scribed by Recchia, F.; Candeloro, G.; Desideri, G.; Necozione, S.; Recchia, C.O.C.; Rea, S.

Book ID: 123449022
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)71641-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of UCN-01 in combinatio

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

✍ Cynthia X. Ma, Matthew J. C. Ellis, Gina R. Petroni, Zhanfang Guo, Shi-rong Cai, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 466 KB

Phase 2 trial of everolimus and carbopla

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer

✍ Singh, Jasmeet; Novik, Yelena; Stein, Stacey; Volm, Matthew; Meyers, Marlene; Sm 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 239 KB

TBCRC 018: phase II study of iniparib in

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

✍ Carey Anders,Allison M. Deal,Vandana Abramson… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 702 KB

Nearly half of patients with advanced triple negative breast cancer (TNBC) develop brain metastases (BM) and most will also have uncontrolled extracranial disease. This study evaluated the safety and efficacy of iniparib, a small molecule anti-cancer agent that alters reactive oxygen species tumor m

5164 POSTER Phase II Study of Neoadjuvan

5164 POSTER Phase II Study of Neoadjuvant S-1 Combined With Paclitaxel Followed by FEC in Patients With Breast Cancer

✍ Ikeda, T.; Kamo, N.; Shiga, C.; Sasajima, Y.; Imamura, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Randomized phase II study of sunitinib v

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

✍ Curigliano, Giuseppe; Pivot, Xavier; Cortés, Javer; Elias, Anthony; Cesari, Ross 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 723 KB

494 Phase II study of S-1 in combination

494 Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)

✍ U. Toh; T. Fukushima; M. Fukunaga; N. Iwakuma; M. Takenaka; H. Otsuka; K. Shirou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB